Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
6.940
+0.030 (+0.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
Psychedelic Stock Gainers And Losers From January 24, 2023
January 24, 2023
Via
Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
January 24, 2023
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer.
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
January 23, 2023
Via
Benzinga
Largest Psychedelic Stocks +3% This Week; Now +15% YTD
January 21, 2023
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different...
Via
Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
January 20, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
January 19, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023
January 17, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
January 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
January 10, 2023
Via
Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
January 19, 2023
A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before...
Via
Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
January 18, 2023
Via
Benzinga
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On?
January 18, 2023
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday.
Via
Benzinga
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances
January 18, 2023
Once considered the realm of ancient civilizations and countercultures, psychedelics have in the past few years been seeing increasing interest.
Via
Benzinga
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
January 17, 2023
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.
Via
Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
January 06, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023
January 05, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
January 04, 2023
Via
Benzinga
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
January 17, 2023
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major...
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
January 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023
January 13, 2023
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 12, 2023
Via
Benzinga
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
January 12, 2023
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 2, 2023
January 02, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 29, 2022
December 29, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
January 09, 2023
Via
Benzinga
My "Rags-To-Riches" Portfolio For 2023: An Introduction
January 08, 2023
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up?
Via
Talk Markets
Psychedelic Stock Gainers And Losers From January 3, 2023
January 03, 2023
Via
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
What a year for psychedelics!
Via
Benzinga
6 Largest Psychedelic Drug Stocks Were -20% In December
January 02, 2023
The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 30, 2022
December 30, 2022
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.